ESC 365 - Ghrelin-HF: intravenous ghrelin in heart failure with reduced ejection fraction

HFA Premium Access

Ghrelin-HF: intravenous ghrelin in heart failure with reduced ejection fraction

Session: Late-Breaking Clinical Trials - Pharmacotherapy

Topic: Pharmacotherapy

Speaker: Professor L. Lund (Stockholm, SE)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

61 presentations

10 followers

3 more presentations in this session

SQI 01-01 and SUBCUT-HF I: Novel preparation of subcutaneous furosemide

Speaker: Doctor J. Osmanska (Glasgow, GB)

REC-DUT-002 - A regenerative pharmacological approach shortly after STEMI is feasible and promising

Speaker: Associate Professor M. Wallner (Graz, AT)

SERENADE: Macitentan in heart failure with preSERved ejEction fractioN and pulmonAry vascular DiseasE

Speaker: Professor A. Voors (Groningen, NL)

Access the full session

Late-Breaking Clinical Trials - Pharmacotherapy

Speakers: Professor L. Lund, Doctor J. Osmanska, Associate Professor M. Wallner, Professor A. Voors

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources